Clinical Trials Directory

Trials / Unknown

UnknownNCT01322373

A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test

Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test: A Follow-up Study

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Orasi Medical, Inc. · Industry
Sex
All
Age
20 Years – 92 Years
Healthy volunteers
Accepted

Summary

This follow-up study is designed to obtain longitudinal clinical and MEG scan data to gain information on Alzheimer's disease (AD) progression, the stability of healthy control (HC) MEG scan data, to enrich the Orasi database of AD and HC subjects, and is intended to extend the capabilities of the Synchronous Neural Interaction® (SNI) test, which is under development by the sponsor, Orasi Medical. The current study is intended to extend the database of AD and HC MEG scans and will include patients who previously enrolled and completed Orasi Protocol ADG 08-01. This study will include MEG scans on up to approximately 50 AD subjects and 70 HC subjects. Additionally, AD subjects will complete 3 standard functional tests while HC subjects will complete 2 standard functional tests. ApoE genotyping also will be determined for all subjects. The results generated in this study will be used to improve the accuracy of the SNI test for diagnosing and tracking the progression of AD.

Conditions

Timeline

Start date
2011-03-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2011-03-24
Last updated
2011-03-24

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01322373. Inclusion in this directory is not an endorsement.